Vaccine Immunity and Inflammation in the Aging Person Living With HIV
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Age\>=18 years
• HIV Diagnosis
• On Antiretroviral Therapy with HIV Viral Load\<200 within last year
Locations
United States
Minnesota
Hennepin Healthcare System
RECRUITING
Minneapolis
Contact Information
Primary
Anne Frosch, MD
Anne.Frosch@hcmed.org
(612)-283-4349
Backup
Marya Abd El Hadi, BSc
MAbdElHadi@hhrinstitute.org
(612)-873-6252
Time Frame
Start Date: 2024-07-08
Estimated Completion Date: 2029-06-30
Participants
Target number of participants: 250
Treatments
Experimental: Pneumococcal Vaccination
All participants will receive a pneumococcal vaccine.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Aging (NIA)
Leads: Hennepin Healthcare Research Institute